» Articles » PMID: 18554199

Sudden Death in a Young Man with Catecholaminergic Polymorphic Ventricular Tachycardia and Paroxysmal Atrial Fibrillation

Overview
Date 2008 Jun 17
PMID 18554199
Citations 38
Authors
Affiliations
Soon will be listed here.
Abstract

Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a familial condition that presents with exercise-induced syncope or sudden death in children or young adults. In most cases the disease is caused by a mutation in the cardiac ryanodine receptor (RyR2) gene. Current evidence suggests that primary therapy for CPVT is beta blockade and implantable cardioverter defibrillator (ICD) placement. There is a recent report of a patient with CPVT who died despite appropriate ICD therapies, and we report a similar case. Our patient died after probably initially receiving inappropriate ICD shocks for atrial fibrillation. We recommend that utmost efforts should be made to prevent shocks including repeated exercise testing to confirm suppression of PVT.

Citing Articles

Novel variants in leading to catecholaminergic polymorphic ventricular tachycardia.

Jones D, Hartung J, Lasalle E, Borquez A, Murillo V, Guidugli L Life Sci Alliance. 2024; 7(8).

PMID: 38777371 PMC: 11111969. DOI: 10.26508/lsa.202402572.


Catecholaminergic Polymorphic Ventricular Tachycardia: Clinical Characteristics, Diagnostic Evaluation and Therapeutic Strategies.

Aggarwal A, Stolear A, Alam M, Vardhan S, Dulgher M, Jang S J Clin Med. 2024; 13(6).

PMID: 38542006 PMC: 10971616. DOI: 10.3390/jcm13061781.


receptor gene mutation associated with catecholaminergic polymorphic ventricular tachycardia in children: a case report & literature review.

Abdullah N, Ali A Transl Pediatr. 2024; 13(2):359-369.

PMID: 38455755 PMC: 10915435. DOI: 10.21037/tp-23-255.


Atrioventricular Nodal Ablation Is Not an Effective Treatment Strategy in Catecholaminergic Polymorphic Ventricular Tachycardia.

Asaki S, Kessler D, Nayak A, Kim J, Miyake C Tex Heart Inst J. 2023; 50(3).

PMID: 37268281 PMC: 10353275. DOI: 10.14503/THIJ-22-7974.


Implantable defibrillators in primary prevention of genetic arrhythmias. A shocking choice?.

Corrado D, Link M, Schwartz P Eur Heart J. 2022; 43(32):3029-3040.

PMID: 35725934 PMC: 9443985. DOI: 10.1093/eurheartj/ehac298.